vical.com | Brickell Biotech, Inc – Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: http://brickellbio.com/wp-sitemap.xml Sitemap: http://brickellbio.com/sitemap.xml

Meta Tags

Title	Brickell Biotech, Inc – Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused
Description	INNOVATIVE AND Company Our Vision Leadership Board of Directors Partner with Us Compliance Hotline R&D Pipeline BBI-02 BBI-03 BBI-10 Next-Generation Kinase Inhibitors Cl
Keywords	N/A

Server Information

WebSite	vical.com
Host IP	35.227.175.142
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

vical.com Valuation

US$2,123

Last updated: 2022-08-22 07:09:14

vical.com has Semrush global rank of 0. vical.com has an estimated worth of US$ 2,123, based on its estimated Ads revenue. vical.com receives approximately 244 unique visitors each day. Its web server is located in United States, with IP address 35.227.175.142. According to SiteAdvisor, vical.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$2,123
Daily Ads Revenue	US$1
Monthly Ads Revenue	US$58
Yearly Ads Revenue	US$705
Daily Unique Visitors	16
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
vical.com.	A	7200	IP: 35.227.175.142
vical.com.	NS	7200	NS Record: ns28.worldnic.com.
vical.com.	NS	7200	NS Record: ns27.worldnic.com.
vical.com.	MX	3600	MX Record: 5 us-smtp-inbound-2.mimecast.com.
vical.com.	MX	3600	MX Record: 1 us-smtp-inbound-1.mimecast.com.
vical.com.	TXT	7200	TXT Record: google-site-verification=tjHvTMLXvSVhZfuc0GZ5go77DZgUlgRUr_INlLUrPCY
vical.com.	TXT	7200	TXT Record: v=spf1 include:spf.intermedia.net ~all
vical.com.	TXT	7200	TXT Record: google-site-verification=tC8r92OyMP1tSITHV7lIn_geU-a_a10BOWOFxsIo4AI

HtmlToTextCheckTime:2022-08-22 07:09:14

Company Our Vision Leadership Board of Directors Partner with Us Compliance Hotline R&D Pipeline BBI-02 BBI-03 BBI-10 Next-Generation Kinase Inhibitors Clinical Trials Therapeutic Areas Immunology DYRK1A in Autoimmunity STING in Inflammation Neuroinflammation Investors Investor Overview News Events & Presentations IR Calendar Governance Leadership Board of Directors Committee Composition Governance Documents SEC Filings Join Us Our Values Careers Our Culture Benefits Contact Us Making Medicine™ VIEW OUR PIPELINE » Fresh Tracks in Developing for VIEW OUR PIPELINE » novel treatments diseases debilitating INNOVATIVE AND DIFFERENTIATED Striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoimmune, inflammatory and other debilitating diseases. More About Brickell OUR RESEARCH Our current pipeline aims to disrupt existing treatment paradigms and features new molecular entities with first-in-class potential as

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Mon, 20 Dec 2021 13:11:43 GMT
Content-Type: text/html; charset=UTF-8
Content-Length: 0
Connection: keep-alive
Keep-Alive: timeout=20
Expires: Mon, 20 Dec 2021 10:45:39 GMT
X-Redirect-By: WordPress
Location: http://brickellbio.com/
X-Powered-By: WP Engine
X-Cacheable: non200
Cache-Control: max-age=600, must-revalidate
X-Cache: HIT: 1
X-Cache-Group: normal

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Mon, 20 Dec 2021 13:11:43 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Keep-Alive: timeout=20
Location: https://brickellbio.com/

HTTP/2 200 
server: nginx
date: Mon, 20 Dec 2021 13:11:44 GMT
content-type: text/html; charset=UTF-8
content-length: 205327
vary: Accept-Encoding
vary: Accept-Encoding
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 3
x-cache-group: normal
accept-ranges: bytes

vical.com Whois Information

Domain Name: VICAL.COM
Registry Domain ID: 2383495_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2020-07-05T02:46:50Z
Creation Date: 1996-11-20T05:00:00Z
Registry Expiry Date: 2028-11-19T05:00:00Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: ok https://icann.org/epp#ok
Name Server: NS27.WORLDNIC.COM
Name Server: NS28.WORLDNIC.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-12-24T08:14:58Z <<<

vical.com valuation and analysis